1. Home
  2. MYFW vs GNFT Comparison

MYFW vs GNFT Comparison

Compare MYFW & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYFW
  • GNFT
  • Stock Information
  • Founded
  • MYFW 2002
  • GNFT 1999
  • Country
  • MYFW United States
  • GNFT France
  • Employees
  • MYFW N/A
  • GNFT N/A
  • Industry
  • MYFW Major Banks
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MYFW Finance
  • GNFT Health Care
  • Exchange
  • MYFW Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • MYFW 201.1M
  • GNFT 216.7M
  • IPO Year
  • MYFW 2018
  • GNFT 2019
  • Fundamental
  • Price
  • MYFW $22.74
  • GNFT $4.23
  • Analyst Decision
  • MYFW Buy
  • GNFT Strong Buy
  • Analyst Count
  • MYFW 2
  • GNFT 2
  • Target Price
  • MYFW $24.25
  • GNFT $11.00
  • AVG Volume (30 Days)
  • MYFW 26.2K
  • GNFT 2.8K
  • Earning Date
  • MYFW 10-23-2025
  • GNFT 09-22-2025
  • Dividend Yield
  • MYFW N/A
  • GNFT N/A
  • EPS Growth
  • MYFW 226.95
  • GNFT N/A
  • EPS
  • MYFW 1.18
  • GNFT 0.03
  • Revenue
  • MYFW $93,514,000.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • MYFW $14.41
  • GNFT $5.44
  • Revenue Next Year
  • MYFW $12.25
  • GNFT N/A
  • P/E Ratio
  • MYFW $19.58
  • GNFT $135.62
  • Revenue Growth
  • MYFW 16.68
  • GNFT 105.01
  • 52 Week Low
  • MYFW $17.10
  • GNFT $2.55
  • 52 Week High
  • MYFW $24.88
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • MYFW 49.52
  • GNFT 54.29
  • Support Level
  • MYFW $22.33
  • GNFT $4.23
  • Resistance Level
  • MYFW $23.74
  • GNFT $4.35
  • Average True Range (ATR)
  • MYFW 0.66
  • GNFT 0.12
  • MACD
  • MYFW -0.03
  • GNFT 0.02
  • Stochastic Oscillator
  • MYFW 58.13
  • GNFT 75.35

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: